Liver transplantation for hilar cholangiocarcinoma—a single-centre experience
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Cholangiocarcinoma is an infrequent malignancy, often unresectable at the time of diagnosis. Liver transplantation may offer a chance for cure, but results in the past have been disappointing, prompting transplant centres to adopt multimodal treatment protocols and extreme patient selection.
This study was designed to evaluate the outcome of patients with irresectable hilar cholangiocarcinoma undergoing liver transplantation in order to determine criteria for patient selection.
We reviewed our prospective cancer registry for patients with hilar cholangiocarcinoma treated by transplantation since 1997. Data were evaluated regarding tumour location, stage, overall survival, recurrence rates and prognostic factors.
Liver transplantation with lymphadenectomy was realised in 16 patients with hilar cholangiocarcinoma. Seven patients received a living donor graft. Lymph node metastases were found in eight patients with a median of 13 harvested nodes and had a statistically significant negative impact on overall survival irrespective of tumour size. Only one patient underwent neoadjuvant brachytherapy and developed fatal septic complications; 3- and 5-year survival rates were 63 and 50 % in lymph node-negative patients without neoadjuvant treatment.
Acceptable survival rates can be achieved by transplantation for hilar cholangiocarcinoma with lymph node metastases as the only exclusion criterion. We recommend staging laparotomy with lymphadenectomy along the common hepatic artery prior to liver transplantation.
- Akamatsu, N, Sugawara, Y, Hashimoto, D (2011) Surgical strategy for bile duct cancer: advances and current limitations. World J Clin Oncol 2: pp. 94-107 CrossRef
- Schule S, Altendorf-Hofmann AK, Knosel T, Utess F, Settmacher U (2012) Diagnostic procedures and results in surgical therapy for cholangiocarcinoma. Zentralbl Chir. doi:10.1055/s-0031-1283831
- Rosen, CB, Heimbach, JK, Gores, GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23: pp. 692-697 CrossRef
- Schnitzbauer, AA, Schlitt, HJ, Geissler, EK (2011) Influence of immunosuppressive drugs on the recurrence of hepatocellular carcinoma after liver transplantation: a gap between basic science and clinical evidence. Transplantation 91: pp. 1173-1176 CrossRef
- Kaiser, GM, Sotiropoulos, GC, Jauch, KW, Lohe, F, Hirner, A, Kalff, JC, Konigsrainer, A, Steurer, W, Senninger, N, Brockmann, JG, Schlitt, HJ, Zulke, C, Buchler, MW, Schemmer, P, Settmacher, U, Hauss, J, Lippert, H, Hopt, UT, Otto, G, Heiss, MM, Bechstein, WO, Timm, S, Klar, E, Holscher, AH, Rogiers, X, Stangl, M, Hohenberger, W, Muller, V, Molmenti, EP, Fouzas, I, Erhard, J, Malago, M, Paul, A, Broelsch, CE, Lang, H (2008) Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc 40: pp. 3191-3193 CrossRef
- Hong, JC, Jones, CM, Duffy, JP, Petrowsky, H, Farmer, DG, French, S, Finn, R, Durazo, FA, Saab, S, Tong, MJ, Hiatt, JR, Busuttil, RW (2011) Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg 146: pp. 683-689 CrossRef
- Friman, S, Foss, A, Isoniemi, H, Olausson, M, Hockerstedt, K, Yamamoto, S, Karlsen, TH, Rizell, M, Ericzon, BG (2011) Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Scand J Gastroenterol 46: pp. 370-375 CrossRef
- Robles, R, Figueras, J, Turrion, VS, Margarit, C, Moya, A, Varo, E, Calleja, J, Valdivieso, A, Valdecasas, JC, Lopez, P, Gomez, M, Vicente, E, Loinaz, C, Santoyo, J, Fleitas, M, Bernardos, A, Llado, L, Ramirez, P, Bueno, FS, Jaurrieta, E, Parrilla, P (2004) Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239: pp. 265-271 CrossRef
- Sotiropoulos, GC, Kaiser, GM, Lang, H, Molmenti, EP, Beckebaum, S, Fouzas, I, Sgourakis, G, Radtke, A, Bockhorn, M, Nadalin, S, Treckmann, J, Niebel, W, Baba, HA, Broelsch, CE, Paul, A (2008) Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience. Transplant Proc 40: pp. 3194-3195 CrossRef
- Gu J, Bai J, Shi X, Zhou J, Qiu Y, Wu Y, Jiang C, Sun X, Xu F, Zhang Y, Ding Y (2012) Efficacy and safety of liver transplantation for patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer. doi:10.1002/ijc.26019
- Becker, NS, Rodriguez, JA, Barshes, NR, O’Mahony, CA, Goss, JA, Aloia, TA (2008) Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 12: pp. 117-122 CrossRef
- Heimbach, JK, Gores, GJ, Haddock, MG, Alberts, SR, Pedersen, R, Kremers, W, Nyberg, SL, Ishitani, MB, Rosen, CB (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82: pp. 1703-1707 CrossRef
- Skipworth, JR, Olde Damink, SW, Imber, C, Bridgewater, J, Pereira, SP, Malago, M (2011) Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther 34: pp. 1063-1078 CrossRef
- Liver transplantation for hilar cholangiocarcinoma—a single-centre experience
Langenbeck's Archives of Surgery
Volume 398, Issue 1 , pp 71-77
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Liver transplantation
- Multimodal therapy
- Industry Sectors
- Author Affiliations
- 1. Department of General, Visceral and Vascular Surgery, University of Jena, Erlanger Allee 101, 07747, Jena, Germany
- 2. Department of Nuclear Medicine, University of Jena, Jena, Germany
- 3. Institute of Pathology, University of Jena, Jena, Germany